Federal Register / Vol. 63, No. 72 /Wednesday, April 15, 1998 / Notices 18427

over the intermeeting period relative to

the currencies of several Asian

developing countries, but it has

registered only a small increase on

average in relation to the currencies of

major industrial nations.

M2 and M3 continued to grow at

relatively rapid rates in December and

apparently also in January. From the

fourth quarter of 1996 to the fourth

quarter of 1997, M2 expanded at a rate

somewhat above the upper bound of its

range for the year and M3 at a rate

substantially above the upper bound of

its range. Total domestic nonfinancial

debt expanded in 1997 at a pace

somewhat below the middle of its range.

The Federal Open Market Committee

seeks monetary and financial conditions

that will foster price stability and

promote sustainable growth in output.

In furtherance of these objectives, the

Committee at this meeting established

ranges for growth of M2 and M3 of 1 to

5 percent and 2 to 6 percent

respectively, measured from the fourth

quarter of 1997 to the fourth quarter of

1998. The range for growth of total

domestic nonfinancial debt was set at 3

to 7 percent for the year. The behavior

of the monetary aggregates will continue

to be evaluated in the light of progress

toward price level stability, movements

in their velocities, and developments in

the economy and financial markets.

In the implementation of policy for

the immediate future, the Committee

seeks conditions in reserve markets

consistent with maintaining the federal

funds rate at an average of around 5-1/

2 percent. In the context of the

Committee’s long-run objectives for

price stability and sustainable economic

growth, and giving careful consideration

to economic, financial, and monetary

developments, a slightly higher federal

funds rate or a slightly lower federal

funds rate might be acceptable in the

intermeeting period. The contemplated

reserve conditions are expected to be

consistent with some moderation in the

growth in M2 and M3 over coming

months.

By order of the Federal Open Market

Committee, April 6, 1998.

Donald L. Kohn,

Secretary, Federal Open Market Committee.

[FR Doc. 98–9886 Filed 4–14–98; 8:45 am]

BILLING CODE 6210–01–F

FEDERAL RESERVE SYSTEM

Sunshine Act Meeting

TIME AND DATE: 11:00 a.m., Monday,

April 20, 1998.

PLACE: Marriner S. Eccles Federal

Reserve Board Building, 20th and C

Streets, N.W., Washington, D.C. 20551.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

1. Personnel actions (appointments,

promotions, assignments,

reassignments, and salary actions)

involving individual Federal Reserve

System employees.

2. Any items carried forward from a

previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION:

Joseph R. Coyne, Assistant to the Board;

202–452–3204.

SUPPLEMENTARY INFORMATION: You may

call 202–452–3206 beginning at

approximately 5 p.m. two business days

before the meeting for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting; or you may

contact the Board’s Web site at http://

www.bog.frb.fed.us for an electronic

announcement that not only lists

applications, but also indicates

procedural and other information about

the meeting.

Dated: April 10, 1998.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 98–10042 Filed 4–10–98; 4:30 pm]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee on Immunization

Practices; Charter Renewal

This gives notice under the Federal

Advisory Committee Act (Pub. L. 92–

463) of October 6, 1972, that the

Advisory Committee on Immunization

Practices (ACIP), Centers for Disease

Control and Prevention (CDC),

Department of Health and Human

Services, has been renewed for a 2-year

period beginning April 1, 1998, through

April 1, 2000.

For further information, contact Dixie

E. Snider, Jr., M.D., Executive Secretary,

ACIP, CDC, 1600 Clifton Road, NE,

(M/S D–50), telephone 404/639–7240 or

fax 404/639–7342.

Dated: April 9, 1998.

Nancy C. Hirsch,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 98–9912 Filed 4–14–98; 8:45 am]

BILLING CODE 4861–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Announcement 98023]

Human Immunodeficiency Virus (HIV),

Sexually Transmitted Diseases (STDs),

and Tuberculosis (TB) Related Applied

Research Projects

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of funds beginning in fiscal

year (FY) 1998 for cooperative

agreements to conduct human

immunodeficiency virus (HIV), sexually

transmitted diseases (STDs), and

tuberculosis (TB) related applied

research into the control and prevention

of HIV, STDs and TB. The purpose of

this program is to encourage new and

innovative methods to further the

prevention of HIV, STDs and TB

infection. Projects that will be

considered for funding are applied

research into the control and prevention

of HIV, STDs, or TB. This program

addresses the ‘‘Healthy People 2000’’

priority area(s) HIV Infection, Sexually

Transmitted Diseases, and

Immunization and Infectious Diseases.

National Program Goals

CDC’s national strategic goals for the

programs supported by the National

Center for HIV, STDs and TB Prevention

are:

1. Increase public understanding of,

involvement in, and support for HIV,

STDs, and TB prevention.

2. Ensure completion of therapy for

persons identified with active TB or TB

infection.

3. Prevent or reduce behaviors or

practices that place persons at risk for

HIV and STDs infection or, if already

infected, place others at risk.

4. Increase individual knowledge of

HIV serostatus and improve referral

systems to appropriate prevention and

treatment services.

5. Assist in building and maintaining

the necessary State, local, and

community infrastructure and technical

capacity to carry out necessary

prevention programs.

6. Strengthen the current systems and

develop new systems to accurately

monitor HIV, STDs, and TB, as a basis

for assessing and directing prevention

programs.

B. Eligible Applicants

Eligible applicants will include

universities, colleges, research

institutions, hospitals, public and